- Filed
- Jun 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 63.38M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 62.92M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −€33.28M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −€34.75M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | €103.58M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | €144.22M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | €241.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | €251.94M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −€6.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | €40.58M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | €158.87M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | €196.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | €105.74M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | €94M |
| Current Assets | Q1 2025 · Mar 31, 2025 | €132.67M |
| Current Assets | Q1 2025 · Dec 31, 2024 | €170.67M |
| Total Assets | Q1 2025 · Mar 31, 2025 | €166.94M |
| Total Assets | Q1 2025 · Dec 31, 2024 | €205.23M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −€0.83 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −€0.68 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −€0.83 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −€0.68 |
| Rd Expense | Q1 2025 · Mar 31, 2025 | €39.3M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | €35.74M |
| Net Income | Q1 2025 · Mar 31, 2025 | −€52.37M |
| Net Income | Q1 2025 · Mar 31, 2024 | −€42.87M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −€47.2M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −€44.67M |